🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the proportion of patients with an urticaria control test \[UCT\] ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2015-04-22
Trial ID
NCT02550106
Treatments Being Tested
The first phase of this study will be a parallel, 12-week treatment, Phase ...
Status
Completed
Location
Investigational Site Number : 0320006
Start Date
2021-11-24
Trial ID
NCT05107115
Treatments Being Tested
To provide elotuzumab treatment for single-patient use....
Status
No Longer Available
Location
Icahn School.of Medicine at Mount Sinai
Start Date
TBD
Trial ID
NCT02541643
Treatments Being Tested
The purpose of this study is to evaluate sacituzumab tirumotecan versus pem...
Status
Active Not Recruiting
Location
Kaiser Permanente - Oakland ( Site 0054)
Start Date
2024-06-11
Trial ID
NCT06305754
This study will compare how safe and effective sacituzumab tirumotecan is v...
Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center ( Site 0119)
Start Date
2024-05-03
Trial ID
NCT06356311
The study is a Phase II, dose-ranging, multicenter, randomized, double-blin...
Status
Completed
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00866788
Treatments Being Tested
The goal of this clinical trial is to learn if diphenhydramine can improve ...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2024-12
Trial ID
NCT06704620
Treatments Being Tested
Researchers are looking for new ways to treat people with endometrial cance...
Status
Active Not Recruiting
Location
USA Mitchell Cancer Institute ( Site 4142)
Start Date
2023-12-06
Trial ID
NCT06132958
Treatments Being Tested
The purpose of this study was to evaluate the safety, tolerability and effi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-01-15
Trial ID
NCT05048342
Treatments Being Tested
Researchers are looking for new ways to treat esophageal squamous cell carc...
Status
Recruiting
Location
UPMC Hillman Cancer Center ( Site 1904)
Start Date
2025-07-30
Trial ID
NCT06780111